Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Axonics Modulation Technologies (AXNX)
NASDAQ:AXNX
RESEARCH TOOLSreports
Axonics Modulation Technologies (AXNX) Stock Price & Analysis
233 Followers
AXNX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$48.30 - $69.68
Previous Close$68.19
Volume81.33K
Average Volume (3M)356.59K
Market Cap
$3.49B
Enterprise Value$3.18B
Total Cash (Recent Filing)$332.81M
Total Debt (Recent Filing)$31.61M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Aug 07, 2024EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding51,018,478
10 Day Avg. Volume360,560
30 Day Avg. Volume356,594
Standard Deviation0.12
R-Squared0.14
Alpha0.00863
Financial Highlights & Ratios
Price to Book (P/B)7.55
Price to Sales (P/S)9.41
Price to Cash Flow (P/CF)153.10
P/FCF Ratio195.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.21
Enterprise Value/Gross Profit11.57
Enterprise Value/Ebitda-1.62K
Forecast
1Y Price Target
$71.00Price Target Upside3.76% Upside
Rating ConsensusHold
Number of Analyst Covering3
Axonics Modulation Technologies News
Bulls Say, Bears Say
Bulls Say
AcquisitionBoston Scientific announced a definitive agreement to acquire AXNX, providing a significant premium and underscoring the strategic value of AXNX's product portfolio.
Financial PerformanceAXNX reported preliminary revenue that exceeded expectations, indicating robust growth and market strength.
Market OutlookThe AXNX and BSX deal may inspire confidence and signal an uptick in M&A activities within the sector due to attractive valuations.
Bears Say
Financial HealthAXNX's net debt is reported at $325 million, indicating a significant financial liability.
Investment OutlookAnalyst recommends reevaluating AXNX shares following a downgrade in rating, implying a cautious approach to investment.
Stock RatingDowngrading AXNX shares from Outperform to Market Perform.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AXNX FAQ
What was Axonics Modulation Technologies’s price range in the past 12 months?
Axonics Modulation Technologies lowest stock price was $48.30 and its highest was $69.68 in the past 12 months.
What is Axonics Modulation Technologies’s market cap?
Currently, no data Available
When is Axonics Modulation Technologies’s upcoming earnings report date?
Axonics Modulation Technologies’s upcoming earnings report date is Aug 07, 2024 which is in 12 days.
How were Axonics Modulation Technologies’s earnings last quarter?
Axonics Modulation Technologies released its earnings results on Apr 30, 2024. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.061 by -$0.319.
Is Axonics Modulation Technologies overvalued?
According to Wall Street analysts Axonics Modulation Technologies’s price is currently Undervalued.
Does Axonics Modulation Technologies pay dividends?
Axonics Modulation Technologies does not currently pay dividends.
What is Axonics Modulation Technologies’s EPS estimate?
Axonics Modulation Technologies’s EPS estimate is $0.1.
How many shares outstanding does Axonics Modulation Technologies have?
Axonics Modulation Technologies has 51,018,480 shares outstanding.
What happened to Axonics Modulation Technologies’s price movement after its last earnings report?
Axonics Modulation Technologies reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.061. Following the earnings report the stock price went up 0.451%.
Which hedge fund is a major shareholder of Axonics Modulation Technologies?
Among the largest hedge funds holding Axonics Modulation Technologies’s share is Soros Fund Mangment LLC. It holds Axonics Modulation Technologies’s shares valued at 20M.
---
Axonics Modulation Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$71.00 (3.76% Upside)
$71.00 (3.76% Upside)
Blogger Sentiment
Bullish
AXNX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 50.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.13%
12-Months-Change
Fundamentals
Return on Equity
-2.65%
Trailing 12-Months
Asset Growth
7.49%
Trailing 12-Months
Company Description
Axonics Modulation Technologies
Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.
---
AXNX Earnings Call
Q3 2023
0:00 / 0:00
---
AXNX Stock 12 Month Forecast
Average Price Target
$71.00
▲(3.76% Upside)
Technical Analysis
Best Analysts Covering AXNX
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+23.88%
reiterated a buy rating 9 months ago
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.88% per trade.
---